"ZERO-DOLLAR COPAY" BOOSTS GENERIC USE
Health plans that switch to a "Zero-DollarCopay" system can reduce their prescriptiondrug costs significantly by encouraginggreater use of generic pharmaceuticals,researchers at Express Scripts said. A newstudy released by the pharmacy benefit managementfirm concluded that temporarilywaiving patient copay requirements forlower-cost generic versions will save money for both theinsurer and the patient.
From the patient's perspective, waiving the copay for a 4-to6-month period would yield out-of-pocket savings averagingabout $50 per patient, Express Scripts said. Adding in the savingsthat would accrue to plan sponsors, the researchersestimate that the nation's total drug bill could dropby as much as $22 billion annually by maximizinggeneric usage.
Although those savings are predicated onpatient response to the zero-dollar-copayincentives, Julayna Meyer, the company's vicepresident of research and trend management,says patients are likely to jump on board."Today's health care consumers understand the importance ofmaking a smart choice with regard to prescription drugs andrespond well to the incentive that has been made availablethrough this program," she said.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
Evaluation of Pharmacist-Driven Penicillin Allergy ReconciliationSeptember 17th 2025
Pharmacists Can Apply Their Expertise to the Medical Psilocybin ActSeptember 16th 2025
From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy ResearchSeptember 15th 2025
